Nagarkatti N

No ORCID on file · 2 papers in corpus
2022
Clinicopathologic characteristics and oncologic outcomes in adenosarcoma of gynecologic sites.
Gynecologic oncology reports ·doi:10.1016/j.gore.2021.100913

ObjectiveTo examine clinicopathologic characteristics and oncologic outcomes of patients diagnosed with Mullerian adenosarcoma and to evaluate ovarian preservation as a practical management option in early-stage disease.MethodsA retrospecti…

2020
Derangements in HUWE1/c-MYC pathway confer sensitivity to the BET bromodomain inhibitor GS-626510 in uterine cervical carcinoma.
Gynecologic Oncology ·doi:10.1016/j.ygyno.2020.06.484

ObjectiveWhole-exome-sequencing (WES) studies reported c-MYC gene-amplification and HUWE1 gene deletion/mutations in a significant number of cervical-cancer-patients (CC) suggesting HUWE1/c-MYC pathway as potential therapeutic target. We in…